Janus Henderson Group’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $30.9M | Sell |
642,277
-70,334
| -10% | -$3.28M | 0.01% | 510 |
|
|
2025
Q4 | $34.5M | Sell |
712,611
-35,173
| -5% | -$1.74M | 0.02% | 489 |
|
|
2025
Q3 | $35.3M | Sell |
747,784
-28,058
| -4% | -$1.35M | 0.02% | 484 |
|
|
2025
Q2 | $37.5M | Sell |
775,842
-55,060
| -7% | -$2.81M | 0.02% | 439 |
|
|
2025
Q1 | $46.4M | Sell |
830,902
-31,618
| -4% | -$1.71M | 0.03% | 390 |
|
|
2024
Q4 | $41.6M | Sell |
862,520
-19,162
| -2% | -$974K | 0.02% | 416 |
|
|
2024
Q3 | $50.8M | Buy |
881,682
+92,015
| +12% | +$4.97M | 0.03% | 386 |
|
|
2024
Q2 | $38.3M | Buy |
789,667
+218,413
| +38% | +$10.5M | 0.02% | 437 |
|
|
2024
Q1 | $27.8M | Sell |
571,254
-88,944
| -13% | -$4.34M | 0.02% | 507 |
|
|
2023
Q4 | $32.8M | Sell |
660,198
-116,812
| -15% | -$5.71M | 0.02% | 456 |
|
|
2023
Q3 | $41.7M | Buy |
777,010
+12,122
| +2% | +$646K | 0.03% | 397 |
|
|
2023
Q2 | $41.2M | Buy |
764,888
+55,130
| +8% | +$2.97M | 0.03% | 425 |
|
|
2023
Q1 | $38.6M | Buy |
709,758
+9,443
| +1% | +$459K | 0.03% | 435 |
|
|
2022
Q4 | $33.9M | Sell |
700,315
-481,021
| -41% | -$21.1M | 0.02% | 457 |
|
|
2022
Q3 | $44.9M | Buy |
1,181,336
+605,307
| +105% | +$27M | 0.02% | 527 |
|
|
2022
Q2 | $28.8M | Buy |
576,029
+22,533
| +4% | +$1.2M | 0.02% | 507 |
|
|
2022
Q1 | $28.4M | Buy |
553,496
+18,453
| +3% | +$953K | 0.01% | 663 |
|
|
2021
Q4 | $26.8M | Sell |
535,043
-31,789
| -6% | -$1.57M | 0.01% | 714 |
|
|
2021
Q3 | $27.3M | Sell |
566,832
-35,658
| -6% | -$1.81M | 0.01% | 717 |
|
|
2021
Q2 | $31.7M | Buy |
602,490
+22,154
| +4% | +$1.16M | 0.01% | 674 |
|
|
2021
Q1 | $28.7M | Buy |
580,336
+57,745
| +11% | +$2.77M | 0.01% | 691 |
|
|
2020
Q4 | $25.4M | Sell |
522,591
-7,013
| -1% | -$346K | 0.01% | 704 |
|
|
2020
Q3 | $26.6M | Buy |
529,604
+47,956
| +10% | +$2.47M | 0.01% | 643 |
|
|
2020
Q2 | $24.6M | Buy |
481,648
+28,389
| +6% | +$1.38M | 0.01% | 657 |
|
|
2020
Q1 | $19.8M | Sell |
453,259
-13,400
| -3% | -$641K | 0.01% | 675 |
|
|
2019
Q4 | $23.4M | Sell |
466,659
-50,849
| -10% | -$2.38M | 0.01% | 788 |
|
|
2019
Q3 | $24M | Sell |
517,508
-15,579
| -3% | -$672K | 0.01% | 784 |
|
|
2019
Q2 | $23.1M | Buy |
533,087
+14,094
| +3% | +$599K | 0.01% | 759 |
|
|
2019
Q1 | $23M | Buy |
518,993
+41,296
| +9% | +$1.77M | 0.01% | 756 |
|
|
2018
Q4 | $20.7M | Sell |
477,697
-15,562
| -3% | -$686K | 0.01% | 737 |
|
|
2018
Q3 | $22M | Buy |
493,259
+10,495
| +2% | +$448K | 0.01% | 793 |
|
|
2018
Q2 | $19.3M | Sell |
482,764
-14,657
| -3% | -$577K | 0.01% | 808 |
|
|
2018
Q1 | $19.9M | Sell |
497,421
-6,726
| -1% | -$280K | 0.01% | 794 |
|
|
2017
Q4 | $21.7M | Sell |
504,147
-17,404
| -3% | -$803K | 0.01% | 748 |
|
|
2017
Q3 | $26M | Buy |
521,551
+50,720
| +11% | +$2.45M | 0.02% | 676 |
|
|
2017
Q2 | $22.6M | Buy |
+470,831
| New | +$22.5M | 0.02% | 714 |
|
|
2016
Q4 | – | Sell |
-7,905
| Closed | -$302K | – | 860 |
|
|
2016
Q3 | $302K | Hold |
7,905
| – | – | ﹤0.01% | 802 |
|
|
2016
Q2 | $331K | Hold |
7,905
| – | – | ﹤0.01% | 788 |
|
|
2016
Q1 | $318K | Hold |
7,905
| – | – | ﹤0.01% | 804 |
|
|
2015
Q4 | $337K | Hold |
7,905
| – | – | ﹤0.01% | 782 |
|
|
2015
Q3 | $375K | Sell |
7,905
-205
| -3% | -$10.4K | ﹤0.01% | 771 |
|
|
2015
Q2 | $400K | Buy |
+8,110
| New | +$411K | ﹤0.01% | 803 |
|
Other funds holding SNY
MIP
Janus Henderson Group's SNY Position: Q1 2026 in Review
Janus Henderson Group reduced its Sanofi (SNY) stake by 9.9% in Q1 2026, selling an estimated $3.28M and leaving 642,277 shares worth $30.9M. The position accounts for 0.01% of the portfolio, ranked #510.
Janus Henderson Group first reported a position in SNY in Q2 2015 and has held it in 42 quarters since. The position peaked at $50.8M in Q3 2024. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.
- Janus Henderson Group held 642,277 shares of Sanofi worth $30.9M as of Q1 2026.
- Janus Henderson Group sold 70,334 Sanofi shares in Q1 2026, an estimated $3.28M.
- Sanofi made up 0.01% of Janus Henderson Group's portfolio in Q1 2026, its #510 holding.
- Janus Henderson Group first reported a position in Sanofi in Q2 2015 and has held it in 42 quarters since.
- Janus Henderson Group's Sanofi position peaked at $50.8M in Q3 2024.
- 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.
Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.